- 专利标题： HETEROCYCLIC NMDA ANTAGONISTS
-
申请号： US17755907申请日： 2020-11-12
-
公开(公告)号： US20230002318A1公开(公告)日： 2023-01-05
- 发明人: Shuhei IKEDA , Makoto KAMATA , Yuya OGURO , Jumpei AIDA , Taisuke TAWARAISHI , Takeshi WAKABAYASHI , Norio OYABU , Atsuko OCHIDA , Kouichi IWANAGA , Satoshi YAMAMOTO , Masataka MURAKAMI , Minoru NAKAMURA , Fumie YAMAGUCHI , Takafumi YUKAWA
- 申请人： TAKEDA PHARMACEUTICAL COMPANY LIMITED
- 申请人地址： JP Osaka-shi, Osaka
- 专利权人： TAKEDA PHARMACEUTICAL COMPANY LIMITED
- 当前专利权人： TAKEDA PHARMACEUTICAL COMPANY LIMITED
- 当前专利权人地址： JP Osaka-shi, Osaka
- 优先权： JP2019-206311 20191114
- 国际申请： PCT/IB2020/000962 WO 20201112
- 主分类号： C07D207/263
- IPC分类号： C07D207/263 ; C07D401/06 ; A61P25/18
摘要：
A compound of formula (I), or a salt thereof that may have an antagonistic action against an NMDA receptor that includes an NR2B subunit and may be useful as a prophylactic or therapeutic agent for depression, bipolar disorder, migraine, pain, a symptom peripheral to dementia, or the like.
信息查询
IPC分类:
